Literature DB >> 27524626

Structure of Gremlin-2 in Complex with GDF5 Gives Insight into DAN-Family-Mediated BMP Antagonism.

Kristof Nolan1, Chandramohan Kattamuri1, Scott A Rankin2, Randy J Read3, Aaron M Zorn2, Thomas B Thompson4.   

Abstract

The DAN family, including Gremlin-1 and Gremlin-2 (Grem1 and Grem2), represents a large family of secreted BMP (bone morphogenetic protein) antagonists. However, how DAN proteins specifically inhibit BMP signaling has remained elusive. Here, we report the structure of Grem2 bound to GDF5 at 2.9-Å resolution. The structure reveals two Grem2 dimers binding perpendicularly to each GDF5 monomer, resembling an H-like structure. Comparison to the unbound Grem2 structure reveals a dynamic N terminus that undergoes significant transition upon complex formation, leading to simultaneous interaction with the type I and type II receptor motifs on GDF5. Binding studies show that DAN-family members can interact with BMP-type I receptor complexes, whereas Noggin outcompetes the type I receptor for ligand binding. Interestingly, Grem2-GDF5 forms a stable aggregate-like structure in vitro that is not clearly observed for other antagonists, including Noggin and Follistatin. These findings exemplify the structural and functional diversity across the various BMP antagonist families.
Copyright © 2016 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27524626      PMCID: PMC5001929          DOI: 10.1016/j.celrep.2016.07.046

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  25 in total

1.  The structure of the follistatin:activin complex reveals antagonism of both type I and type II receptor binding.

Authors:  Thomas B Thompson; Thomas F Lerch; Robert W Cook; Teresa K Woodruff; Theodore S Jardetzky
Journal:  Dev Cell       Date:  2005-10       Impact factor: 12.270

2.  Expression of gremlin, a bone morphogenetic protein antagonist, in human diabetic nephropathy.

Authors:  Vincent Dolan; Madeline Murphy; Denise Sadlier; David Lappin; Peter Doran; Catherine Godson; Finian Martin; Yvonne O'Meara; Holger Schmid; Anna Henger; Matthias Kretzler; Alejandra Droguett; Sergio Mezzano; Hugh R Brady
Journal:  Am J Kidney Dis       Date:  2005-06       Impact factor: 8.860

3.  Structure of protein related to Dan and Cerberus: insights into the mechanism of bone morphogenetic protein antagonism.

Authors:  Kristof Nolan; Chandramohan Kattamuri; David M Luedeke; Xiaodi Deng; Amrita Jagpal; Fuming Zhang; Robert J Linhardt; Alan P Kenny; Aaron M Zorn; Thomas B Thompson
Journal:  Structure       Date:  2013-07-11       Impact factor: 5.006

Review 4.  The DAN family: modulators of TGF-β signaling and beyond.

Authors:  Kristof Nolan; Thomas B Thompson
Journal:  Protein Sci       Date:  2014-06-02       Impact factor: 6.725

5.  The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites.

Authors:  Hua Gao; Goutam Chakraborty; Ai Ping Lee-Lim; Qianxing Mo; Markus Decker; Alin Vonica; Ronglai Shen; Edi Brogi; Ali H Brivanlou; Filippo G Giancotti
Journal:  Cell       Date:  2012-08-17       Impact factor: 41.582

6.  Crystal structure analysis reveals how the Chordin family member crossveinless 2 blocks BMP-2 receptor binding.

Authors:  Jin-Li Zhang; Li-Yan Qiu; Alexander Kotzsch; Stella Weidauer; Lucy Patterson; Matthias Hammerschmidt; Walter Sebald; Thomas D Mueller
Journal:  Dev Cell       Date:  2008-05       Impact factor: 12.270

7.  The structure of myostatin:follistatin 288: insights into receptor utilization and heparin binding.

Authors:  Jennifer N Cash; Carlis A Rejon; Alexandra C McPherron; Daniel J Bernard; Thomas B Thompson
Journal:  EMBO J       Date:  2009-07-30       Impact factor: 11.598

8.  Molecular recognition of BMP-2 and BMP receptor IA.

Authors:  Sascha Keller; Joachim Nickel; Jin-Li Zhang; Walter Sebald; Thomas D Mueller
Journal:  Nat Struct Mol Biol       Date:  2004-04-04       Impact factor: 15.369

9.  BRITER: a BMP responsive osteoblast reporter cell line.

Authors:  Prem Swaroop Yadav; Paritosh Prashar; Amitabha Bandyopadhyay
Journal:  PLoS One       Date:  2012-05-14       Impact factor: 3.240

10.  Structure of Gremlin-1 and analysis of its interaction with BMP-2.

Authors:  Miglė Kišonaitė; Xuelu Wang; Marko Hyvönen
Journal:  Biochem J       Date:  2016-04-01       Impact factor: 3.857

View more
  18 in total

Review 1.  Bone morphogenetic protein signaling in inflammation.

Authors:  David H Wu; Antonis K Hatzopoulos
Journal:  Exp Biol Med (Maywood)       Date:  2019-02-07

2.  Structural biology of the TGFβ family.

Authors:  Erich J Goebel; Kaitlin N Hart; Jason C McCoy; Thomas B Thompson
Journal:  Exp Biol Med (Maywood)       Date:  2019-10-09

3.  Crystal structure of the WFIKKN2 follistatin domain reveals insight into how it inhibits growth differentiation factor 8 (GDF8) and GDF11.

Authors:  Jason C McCoy; Ryan G Walker; Nathan H Murray; Thomas B Thompson
Journal:  J Biol Chem       Date:  2019-02-27       Impact factor: 5.157

4.  Analysis and identification of the Grem2 heparin/heparan sulfate-binding motif.

Authors:  Chandramohan Kattamuri; Kristof Nolan; Thomas B Thompson
Journal:  Biochem J       Date:  2017-03-08       Impact factor: 3.857

5.  Structural analyses of von Willebrand factor C domains of collagen 2A and CCN3 reveal an alternative mode of binding to bone morphogenetic protein-2.

Authors:  Emma-Ruoqi Xu; Emily E Blythe; Gerhard Fischer; Marko Hyvönen
Journal:  J Biol Chem       Date:  2017-06-05       Impact factor: 5.157

6.  Coordinated Proliferation and Differentiation of Human-Induced Pluripotent Stem Cell-Derived Cardiac Progenitor Cells Depend on Bone Morphogenetic Protein Signaling Regulation by GREMLIN 2.

Authors:  Jeffery B Bylund; Linh T Trinh; Cassandra P Awgulewitsch; David T Paik; Christopher Jetter; Rajneesh Jha; Jianhua Zhang; Kristof Nolan; Chunhui Xu; Thomas B Thompson; Timothy J Kamp; Antonis K Hatzopoulos
Journal:  Stem Cells Dev       Date:  2017-03-20       Impact factor: 3.272

7.  Neuroblastoma suppressor of tumorigenicity 1 is a circulating protein associated with progression to end-stage kidney disease in diabetes.

Authors:  Hiroki Kobayashi; Helen C Looker; Eiichiro Satake; Francesca D'Addio; Jonathan M Wilson; Pierre Jean Saulnier; Zaipul I Md Dom; Kristina O'Neil; Katsuhito Ihara; Bozena Krolewski; Hannah S Badger; Adriana Petrazzuolo; Domenico Corradi; Andrzej Galecki; Parker C Wilson; Behzad Najafian; Michael Mauer; Monika A Niewczas; Alessandro Doria; Benjamin D Humphreys; Kevin L Duffin; Paolo Fiorina; Robert G Nelson; Andrzej S Krolewski
Journal:  Sci Transl Med       Date:  2022-08-10       Impact factor: 19.319

Review 8.  Structural perspective of BMP ligands and signaling.

Authors:  Gregory R Gipson; Erich J Goebel; Kaitlin N Hart; Emily C Kappes; Chandramohan Kattamuri; Jason C McCoy; Thomas B Thompson
Journal:  Bone       Date:  2020-07-27       Impact factor: 4.398

9.  Inhibiting roles of FOXA2 in liver cancer cell migration and invasion by transcriptionally suppressing microRNA-103a-3p and activating the GREM2/LATS2/YAP axis.

Authors:  Guangzhen Ma; Jirong Chen; Tiantian Wei; Jia Wang; Wenshan Chen
Journal:  Cytotechnology       Date:  2021-05-26       Impact factor: 2.040

10.  Deletion of Gremlin-2 alters estrous cyclicity and disrupts female fertility in mice†.

Authors:  Robert T Rydze; Bethany K Patton; Shawn M Briley; Hannia Salazar Torralba; Gregory Gipson; Rebecca James; Aleksandar Rajkovic; Thomas Thompson; Stephanie A Pangas
Journal:  Biol Reprod       Date:  2021-11-15       Impact factor: 4.161

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.